SCHEMBL1581993

SCHEMBL1581993

O=C(O)N1CCC(O)(c2ccc(-c3ccc(Cl)c(Cl)c3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
APP P05067 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
AKR1C3 P42330 1/20 0.43
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
AKR1C2 P52895 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
EPHX2 P34913 1/20 0.43
S1PR1 P21453 1/20 0.42
S1PR5 Q9H228 1/20 0.42
KDM4E B2RXH2 1/20 0.42
DRD2 P14416 2/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3387438 0.88 DRD2 (0.50) MEN1KMT2AEPHX2KDM4EDRD2
SCHEMBL1581501 0.88 DRD2 (0.45) MEN1KMT2AAPPCYP3A4CYP2C9
SCHEMBL1581499 0.85 MEN1 (0.58) MEN1KMT2AKDM4EDRD2OPRM1
SCHEMBL5075026 0.81 DRD2 (0.44) MEN1KMT2AEPHX2KDM4EDRD2
SCHEMBL2229509 0.81 MEN1 (0.62) MEN1KMT2AKDM4EDRD2OPRM1
SCHEMBL1824469 0.80 DRD2 (0.46) MEN1KMT2AEPHX2DRD2OPRM1
SCHEMBL1581749 0.80 OPRM1 (0.51) MEN1KMT2ADRD2OPRM1OPRD1
SCHEMBL1581427 0.80 OPRM1 (0.51) CYP3A4DRD2OPRM1OPRD1OPRK1
SCHEMBL5375143 0.79 KDM4E (0.43) MEN1KMT2AEPHX2KDM4EDRD2
SCHEMBL5381232 0.79 CCR1 (0.50) MEN1KMT2AAPPCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720872-B1 ARYL AND HETEROARYL-PIPERIDINECARBOXYLATE DERIVATIVES, THE PREPARATION AND THE USE THEREOF IN THE FORM OF FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2011-04-20 EP disclosed